0001225208-22-000735.txt : 20220113 0001225208-22-000735.hdr.sgml : 20220113 20220113173734 ACCESSION NUMBER: 0001225208-22-000735 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220113 DATE AS OF CHANGE: 20220113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Swanson James D. CENTRAL INDEX KEY: 0001904785 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 22529919 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 0102 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 3 1 doc3.xml X0206 3 2022-01-03 0 0000200406 JOHNSON & JOHNSON JNJ 0001904785 Swanson James D. ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 1 EVP, Chief Information Officer Common Stock 1084.0000 D Employee Stock Options (Right to Buy) 151.4100 2023-02-10 2030-02-10 Common Stock 16511.0000 D Employee Stock Options (Right to Buy) 164.6200 2024-02-08 2031-02-08 Common Stock 20521.0000 D Restricted Share Units 2024-02-08 Common Stock 1868.0000 D Restricted Share Units 2023-02-10 Common Stock 1291.0000 D Restricted Share Units 2022-11-01 Common Stock 9912.0000 D Vested and exercisable on the third anniversary of the date of the grant. Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant. swansonpoa1.txt Raavi Deol, as attorney-in-fact for James Swanson 2022-01-13 EX-24 2 swansonpoa1.txt POWER OF ATTORNEY Executive Officers Know all persons by these presents, that the undersigned hereby constitutes and appoints each of Matthew Orlando, Renee Brutus, Pinto Adhola, Duane von Arsdale, Raavi Deol and Elizabeth Carew, signing singly, as the undersigned's true and lawful attorneys-in-fact to: (1) complete and execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer of Johnson & Johnson (the "Company"), Forms 3, 4 and 5 (including any amendments thereto) in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder (the "Exchange Act") and Form 144 in accordance with Rule 144 of the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder (the "Securities Act"); (2) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the United States Securities and Exchange Commission (the "SEC") an Application for EDGAR Access (Form ID), including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Exchange Act, or any rule or regulation of the SEC; (3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, 5 and 144 (including any amendments thereto) and timely file such form with the SEC and any stock exchange or similar authority; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, (i) any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act or Rule 144 of the Securities Act or (ii) any liability of the undersigned for failure to comply with such requirements. The undersigned agrees that each such attorney-in-fact may rely entirely on information furnished orally or in writing by or at the direction of the undersigned to the attorney-in-fact. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, 5 and 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the date set forth below. /s/ James Swanson Name: James Swanson Date: January 8, 2022